Sales rise 10.83% to Rs 96.63 crore
Net profit of Lincoln Pharmaceuticals rose 246.67% to Rs 15.60 crore in the quarter ended June 2018 as against Rs 4.50 crore during the previous quarter ended June 2017. Sales rose 10.83% to Rs 96.63 crore in the quarter ended June 2018 as against Rs 87.19 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales96.6387.19 11 OPM %22.436.66 -PBDT23.097.20 221 PBT21.956.24 252 NP15.604.50 247Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)